Mechanism of the Fibroblast Growth Factor 23/α-Klotho Axis in Peripheral Blood Mononuclear Cell Inflammation in Alzheimer’s Disease

References

• Sopjani M, Rinnerthaler M, Kruja J, Dermaku-Sopjani M. 2015. Intracellular signaling of the aging suppressor protein Klotho. Curr Mol Med. 15:27–37.
   PubMed Web of Science ®Google Scholar
• Barnes JW, Duncan D, Helton S, Hutcheson S, Kurundkar D, Logsdon NJ, Locy M, Garth J, Denson R, Farver C, et al. 2019. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 317(1):L141–L154.
   PubMed Web of Science ®Google Scholar
• Briggs R, Kennelly SP, O'Neill D. 2016. Drug treatments in Alzheimer’s disease. Clin Med (Lond). 16:247–53.
   PubMed Web of Science ®Google Scholar
• Cararo-Lopes MM, Mazucanti CHY, Scavone C, Kawamoto EM, Berwick DC. 2017. The relevance of alpha-KLOTHO to the central nervous system: some key questions. Ageing Res Rev. 36:137–48.
   PubMed Web of Science ®Google Scholar
• Cardoso AL, Fernandes A, Aguilar-Pimentel JA, Hrabě de Angelis M, Guedes JR, Brito MA, Ortolano S, Pani G, Athanasopoulou S, Gonos ES, et al. 2018. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev. 47:214–77.
   PubMed Web of Science ®Google Scholar
• Carrillo-Lopez N, Panizo S, Alonso-Montes C, Román-García P, Rodríguez I, Martínez-Salgado C, Dusso AS, Naves M, Cannata-Andía JB, et al. 2016. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int. 90:77–89.
   PubMed Web of Science ®Google Scholar
• Chen CD, Li Y, Chen AK, Rudy MA, Nasse JS, Zeldich E, Polanco TJ, Abraham CR. 2020. Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho. PLoS One. 15:e0226382.
   PubMed Web of Science ®Google Scholar
• Chen D, Xie R, Shu B, Landay AL, Wei C, Reiser J, Spagnoli A, Torquati A, Forsyth CB, Keshavarzian A, et al. 2019. Wnt signaling in bone, kidney, intestine, and adipose tissue and interorgan interaction in aging. Ann N Y Acad Sci. 1442(1):48–60.
   PubMed Web of Science ®Google Scholar
• Chen YX, Huang C, Duan ZB, Xu CY, Chen Y. 2019. Klotho/FGF23 axis mediates high phosphate-induced vascular calcification in vascular smooth muscle cells via Wnt7b/beta-catenin pathway. Kaohsiung J Med Sci. 35:393–400.
   PubMed Web of Science ®Google Scholar
• Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D’Arrigo G, Abd Elhafeez S, Tripepi G, Mallamaci F, Zoccali C, et al. 2016. Intact FGF23 and alpha-Klotho during acute inflammation/sepsis in CKD patients. Eur J Clin Invest. 46:234–41.
   PubMed Web of Science ®Google Scholar
• Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, et al. 2007. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6:734–46.
   PubMed Web of Science ®Google Scholar
• Erben RG. 2016. Update on FGF23 and Klotho signaling. Mol Cell Endocrinol. 432:56–65.
   PubMed Web of Science ®Google Scholar
• Ersoy FF. 2014. A short story of Klotho and FGF23: a deuce of dark side or the savior? Int Urol Nephrol. 46:577–81.
   PubMed Web of Science ®Google Scholar
• Forloni G, Balducci C, Perry G, Avila J, Tabaton M, Zhu X. 2018. Alzheimer’s disease, oligomers, and inflammation. J Alzheimers Dis. 62:1261–76.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Reimers E, Romero-Acevedo L, Espelosín-Ortega E, Martín-González MC, Quintero-Platt G, Abreu-González P, José de-la-Vega-Prieto M, Martínez-Martínez D, Santolaria-Fernández F, et al. 2018. Soluble Klotho and brain atrophy in alcoholism. Alcohol Alcohol. 53:503–10.
   PubMed Web of Science ®Google Scholar
• Irwin MR, Vitiello MV. 2019. Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. Lancet Neurol. 18:296–306.
   PubMed Web of Science ®Google Scholar
• Islam BU, Tabrez S. 2017. Management of Alzheimer’s disease-An insight of the enzymatic and other novel potential targets. Int J Biol Macromol. 97:700–09.
   PubMed Web of Science ®Google Scholar
• Jia L, Pina-Crespo J, Li Y. 2019. Restoring Wnt/beta-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease. Mol Brain. 12:104.
   PubMed Web of Science ®Google Scholar
• Jiang DQ, Wei MD, Wang K-W, Lan Y-X, Zhu N, Wang Y. 2016. Nicotine contributes to the neural stem cells fate against toxicity of microglial-derived factors induced by Abeta via the Wnt/beta-catenin pathway. Int J Neurosci. 126:257–68.
   PubMed Web of Science ®Google Scholar
• Kokras N, Stamouli E, Sotiropoulos I, Katirtzoglou EA, Siarkos KT, Dalagiorgou G, Alexandraki KI, Coulocheri S, Piperi C, Politis AM. 2018. Acetyl cholinesterase inhibitors and cell-derived peripheral inflammatory cytokines in early stages of Alzheimer’s disease. J Clin Psychopharmacol. 38:138–43.
   PubMed Web of Science ®Google Scholar
• Kuro OM. 2019. The Klotho proteins in health and disease. Nat Rev Nephrol. 15:27–44.
   PubMed Web of Science ®Google Scholar
• Lane CA, Hardy J, Schott JM. 2018. Alzheimer’s disease. Eur J Neurol. 25:59–70.
   PubMed Web of Science ®Google Scholar
• Latta CH, Brothers HM, Wilcock DM. 2015. Neuroinflammation in Alzheimer’s disease; A source of heterogeneity and target for personalized therapy. Neuroscience. 302:103–11.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–08.
   PubMed Web of Science ®Google Scholar
• McGrath ER, Himali JJ, Levy D, Conner SC, Pase MP, Abraham CR, Courchesne P, Satizabal CL, Vasan RS, Beiser AS, et al. 2019. Circulating fibroblast growth factor 23 levels and incident dementia: the Framingham heart study. PLoS One. 14:e0213321.
   PubMed Web of Science ®Google Scholar
• Ozben T, Ozben S. 2019. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer’s disease. Clin Biochem. 72:87–89.
   PubMed Web of Science ®Google Scholar
• Ramirez-Serrano CE, Jimenez-Ferrer E, Herrera-Ruiz M, Zamilpa A, Vargas-Villa G, Ramírez-Carreto RJ, Chavarría A, Tortoriello J, Pedraza-Alva G, Pérez-Martínez L, et al. 2019. A Malva parviflora s fraction prevents the deleterious effects resulting from neuroinflammation. Biomed Pharmacother. 118:109349.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Ortiz ME, Diaz-Tocados JM, Muñoz-Castañeda J, Herencia C, Pineda C, Martínez-Moreno J, Montes de Oca A, López-Baltanás R, Alcalá-Díaz J, Ortiz A, et al. 2020. Inflammation both increases and causes resistance to FGF23 in normal and uremic rats. Clin Sci (Lond). 134(1):15–32.
   PubMed Web of Science ®Google Scholar
• Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, Hao Y, Gu Y, Han C. 2020. New mechanism of neuroinflammation in Alzheimer’s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 100:109884.
   PubMed Web of Science ®Google Scholar
• Soria Lopez JA, Gonzalez HM, Léger GC. 2019. Alzheimer’s disease. Handb Clin Neurol. 167:231–55.
   PubMedGoogle Scholar
• Tanaka K, Salunya T, Motomiya Y, Motomiya Y, Oyama Y, Yamakuchi M, Maruyama I. 2017. Decreased expression of thrombomodulin in endothelial cells by fibroblast growth factor-23/alpha-Klotho. Ther Apher Dial. 21:395–404.
   PubMed Web of Science ®Google Scholar
• Tapia-Rojas C, Inestrosa NC. 2018. Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer’s disease. Neural Regen Res. 13:1705–10.
   PubMed Web of Science ®Google Scholar
• Vallee A, Lecarpentier Y, Guillevin R, Vallée JN. 2017. Effects of cannabidiol interactions with Wnt/beta-catenin pathway and PPARgamma on oxidative stress and neuroinflammation in Alzheimer’s disease. Acta Biochim Biophys Sin (Shanghai). 49:853–66.
   PubMed Web of Science ®Google Scholar
• Weller J, Budson A. 2018. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Res. 7:1161.
   Google Scholar
• Yang Y, Zhang Z. 2020. Microglia and Wnt pathways: prospects for inflammation in Alzheimer’s disease. Front Aging Neurosci. 12:110.
   PubMed Web of Science ®Google Scholar